Life ScienceCompany
H-Immune Therapeutics Ownership
Who owns H-Immune Therapeutics?
H-Immune Therapeutics is owned by HiFiBiO Therapeutics. It was acquired on October 15, 2018.
H-Immune Therapeutics Business Overview
Where is H-Immune Therapeutics headquartered?
H-Immune Therapeutics is headquartered in Paris, France.
What sector is H-Immune Therapeutics in?
H-Immune Therapeutics is a life science company.
When was H-Immune Therapeutics founded?
H-Immune Therapeutics was founded in 2016.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.